Answer
Valganciclovir is converted to ganciclovir, whose triphosphate form inhibits viral DNA synthesis by competing with deoxyguanosine triphosphate for incorporation by viral DNA polymerase and by entering viral DNA, terminating or severely limiting further DNA elongation.
Sources for this answer
- Valganciclovir 450 mg film-coated tabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §5.1 Pharmacodynamic properties · Version 5Document updated
Sources checked